Todays Report: Today, Lantheus Holdings Inc. (LNTH) Raised to “Buy” at Zacks Investment Research

Today, Lantheus Holdings Inc. (LNTH) Raised to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Lantheus Holdings Inc. (NASDAQ:LNTH) from a hold rating to a buy rating in a research report released on Wednesday morning. They currently have $9.00 price objective on the stock.

According to Zacks, “Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. “

A number of other research firms also recently weighed in on LNTH. Jefferies Group increased their target price on shares of Lantheus Holdings from $8.00 to $12.00 and gave the company a buy rating in a research report on Monday, August 29th. Credit Suisse Group AG set a $4.00 target price on shares of Lantheus Holdings and gave the company a hold rating in a research report on Friday, August 5th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Lantheus Holdings presently has a consensus rating of Buy and a consensus price target of $7.80.

Lantheus Holdings (NASDAQ:LNTH) opened at 7.70 on Wednesday. The firm’s 50-day moving average is $8.49 and its 200 day moving average is $4.66. Lantheus Holdings has a 12 month low of $1.76 and a 12 month high of $10.10. The firm has a market capitalization of $233.98 million, a P/E ratio of 8.69 and a beta of 0.47.

Lantheus Holdings (NASDAQ:LNTH) last released its earnings results on Thursday, August 4th. The company reported $0.24 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.06 by $0.18. Lantheus Holdings had a net margin of 9.00% and a negative return on equity of 11.75%. The firm earned $78 million during the quarter, compared to the consensus estimate of $72.66 million. On average, analysts expect that Lantheus Holdings will post $0.55 EPS for the current fiscal year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LNTH. BlackRock Institutional Trust Company N.A. increased its position in Lantheus Holdings by 28.4% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 194,308 shares of the company’s stock valued at $367,000 after buying an additional 42,971 shares during the period. Spark Investment Management LLC increased its position in Lantheus Holdings by 541.2% in the first quarter. Spark Investment Management LLC now owns 106,100 shares of the company’s stock valued at $200,000 after buying an additional 89,553 shares during the period. State Street Corp increased its position in Lantheus Holdings by 10.3% in the first quarter. State Street Corp now owns 106,233 shares of the company’s stock valued at $200,000 after buying an additional 9,909 shares during the period. Gabelli Funds LLC increased its position in Lantheus Holdings by 22.2% in the second quarter. Gabelli Funds LLC now owns 165,000 shares of the company’s stock valued at $606,000 after buying an additional 30,000 shares during the period. Finally, GSA Capital Partners LLP increased its position in Lantheus Holdings by 3.7% in the second quarter. GSA Capital Partners LLP now owns 154,322 shares of the company’s stock valued at $566,000 after buying an additional 5,500 shares during the period. 30.15% of the stock is owned by institutional investors.

About Lantheus Holdings

Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.

Related posts

Leave a Comment